Sign in

CIK 0001237831

  • Large accelerated filer

GLOBUS MEDICAL INC

Sign in to watch
Ticker
GMED
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043744954
Phone
+1 610-930-1800
Business address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,794,049
in 3 filings, $425K under 10b5-1 plans

Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$5.4M Director sold 100% of stake
  2. RHOADS ANN D −$425K Director sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-07-22 Douglas Robert Andrew Director Purchase +690 $47.75 $33K 1,390
2020-06-22 Douglas Robert Andrew Director Purchase +700 $48.20 $34K 700
2020-06-11 Huller Kelly SVP, GC, Corporate Secretary Exercise or conversion +9,076 $11.28 $102K 9,076
2020-06-11 Huller Kelly SVP, GC, Corporate Secretary Sale −9,076 $51.00 $463K 0
2020-06-11 Huller Kelly SVP, GC, Corporate Secretary Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −9,076 14,000
2020-05-21 Scavilla Daniel T EVP, Chief Commercial Officer Exercise or conversion +31,250 $25.40 $794K 31,250
2020-05-21 Scavilla Daniel T EVP, Chief Commercial Officer Exercise or conversion +68,750 $25.52 $1.8M 100,000
2020-05-21 Scavilla Daniel T EVP, Chief Commercial Officer Sale −100,000 $55.09 $5.5M 0
2020-05-21 Scavilla Daniel T EVP, Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −31,250 0
2020-05-21 Scavilla Daniel T EVP, Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −68,750 50,000
2020-01-22 ZARRILLI STEPHEN T Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +25,000 25,000
2020-01-22 TOBIN JAMES R Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +25,000 25,000
2020-01-22 Lemaitre Dan Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +25,000 25,000
2020-01-22 Davidar David D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +25,000 25,000
2020-01-22 RHOADS ANN D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +25,000 25,000
2020-01-22 Pfeil Keith W SVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy Class A Common Stock) +40,000 40,000
2020-01-22 Huller Kelly SVP, GC, Corporate Secretary Grant or award · Stock Option (Right to Buy Class A Common Stock) +40,000 40,000
2020-01-22 Scavilla Daniel T EVP, Chief Commercial Officer Grant or award · Stock Option (Right to Buy Class A Common Stock) +80,000 80,000
2020-01-22 Paul David C Executive Chairman Grant or award · Stock Option (Right to Buy Class A Common Stock) +100,000 100,000
2020-01-22 Demski David M President, CEO Grant or award · Stock Option (Right to Buy Class A Common Stock) +175,000 175,000

Page 19 of 25 · 498 trades